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336 Midterm results of mitral valve repair with artificial chordae in children
Kazu Minami, MD, Hideaki Kado, MD, Sadahiro Sai, MD, Hideki Tatewaki, MD,
Yuichi Shiokawa, MD, Atsuhiro Nakashima, MD, Koji Fukae, MD, and
Hitoshi Hirose, MD, FACS, Tokyo, Japan
We evaluated the midterm effectiveness of MV repair with artificial chordal replacement using
ePTFE sutures in 39 children. During the follow-up period (mean, 5 years), 33 (85%) patients
had less than trivial MR. This procedure is safe and effective, with potential for patients’
growth.
343 Risk factors associated with mortality and interventions in 472 neonates with
interrupted aortic arch: A Congenital Heart Surgeons Society study
Brian W. McCrindle, MD, MPH, Christo I. Tchervenkov, MD, Igor E. Konstantinov, MD,
William G. Williams, MD, Rodolfo A. Neirotti, MD, Marshall L. Jacobs, MD, and Eugene H.
Blackstone, MD, for the members of the Congenital Heart Surgeons Society, Toronto, Ontario,
Canada; Montreal, Quebec, Canada; Grand Rapids, Mich; Philadelphia, Pa; and Cleveland,
Ohio
Competing risks methodology was used to determine the prevalence and risk factors for death
and interventions for 472 neonates with IAA. Associated cardiac lesions were major risk factors
for death and procedures for LVOT obstruction, whereas initial repair charcteristics were major
risk factors for arch reinterventions.
351 Hypertrophic obstructive cardiomyopathy: Comparison of outcomes after
myectomy or alcohol ablation adjusted by propensity score
Anthony Ralph-Edwards, MD, Anna Woo, MD, Brian W. McCrindle, MD, MPH,
Jonathan L. Shapero, BSc, Leonard Schwartz, MD, Harry Rakowski, MD,
E. Douglas Wigle, MD, and William G. Williams, MD, Toronto and Kingston, Ontario, Canada
One hundred fifty consecutive patients referred for surgical or alcohol ablation treatment of
HOCM were prospectively assessed for symptom status, hemodynamic results, further
interventions, and survival. Propensity scores adjusted demographic differences between the
treatment groups. Surgical myectomy provides improved symptom relief, hemodynamics, and
freedom from permanent pacing.
359 A novel adhesion barrier facilitates reoperations in complex congenital
cardiac surgery
Thomas Walther, MD, PhD, Ardawan Rastan, MD, Ingo Dähnert, MD,
Volkmar Falk, MD, PhD, Stefan Jacobs, MD, Friedrich W. Mohr, MD, PhD, and
Martin Kostelka, MD, PhD, Leipzig, Germany.
A bioresorbable membrane was applied to reduce surgical adhesions in 350 patients receiving
surgery for congenital heart defects; 30 received reoperations. Application was safe and led to a
significant reduction in tenacity and extent of adhesions as well as duration of reoperation.
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